Zoundream
PrivateLast Round
Seed
Oct 3, 2025
Total Funding Raised
$4.68M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Zoundream operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Seed round in October 2025.
Zoundream is a health-tech company that provides an AI-driven platform for infant cry analysis to translate needs and detect early signs of health conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Health IoT, Consumer Electronics
Business Model
B2B2C
Customer Profile
Subscription SaaS, Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zoundream Comparables
Compare Zoundream with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Crynostics Inc. | 83% | |
| Ubenwa | 82% | |
| First Ascent Inc. | 64% |
For institutional investors. Book with your work email.
Zoundream Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Zoundream Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Granatus Ventures | Seed |
| Secways | Seed |
| Verge HealthTech Fund | Seed |
| Mission Gate | Seed |
| Center for Technological Development and Innovation | Seed |
| TQ Ventures | Seed |
| HITS House of Insurtech Switzerland | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 79% MoM, reaching 1.5K.
- Jul 24, 2026
Monthly visitors increased 154% MoM.
For institutional investors. Book with your work email.
Zoundream Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Zoundream's valuation, stock price, and market status.
Is Zoundream a public or private company?
Zoundream is a private company.
What is the current stock price of Zoundream?
Zoundream is a private company, so its shares have no public market price. Caplight tracks Zoundream's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zoundream worth (valuation)?
Valuation information for Zoundream is not publicly available.
Can I buy Zoundream stock?
Zoundream shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zoundream's last funding round?
Zoundream's most recent funding round was Seed on October 3, 2025.
Who are the main investors in Zoundream?
Key investors in Zoundream include Granatus Ventures, Secways, Verge HealthTech Fund, Mission Gate, Center for Technological Development and Innovation.
Will Zoundream IPO soon?
No public IPO plans have been announced for Zoundream.
How can I track Zoundream secondary market activity?
Caplight tracks bids, offers, and trades in Zoundream's shares on secondary markets.